Infection, COVID-19 Clinical Trial
— CoSigSOfficial title:
Comparison of the Proportion of Covid19 Seroconversion of Caregivers Working or Not in the COVID Sector
According to recent publications, the percentage of caregivers infected with COVID 19 is
evaluated between 10 and 30% . This great variability is due, on the one hand to the
intensity of the influx of covid plus patients and, on the other hand, to the disparity in
the preparation of caregivers in the face of this emergency. Indeed, we can understand that
the strict application of hygiene rules can be faulted in the face of the volume of patients,
the lack of protective equipment and the lack of specific training for caregivers in this
area. As a result, within healthcare teams, there are many questions that generate anxiety:
will I be able to provide care properly while protecting myself from the risk of
contamination? This anxiety is also present and sometimes manifests itself aggressively in
the entourage or in the vicinity of caregivers, due to lack of scientific data adapted to the
local ecology of the crisis.
Thus, the aim of this study is to show that the risk for caregivers of being contaminated by
COVID in an area dedicated to COVID positive patients is no higher than being a caregiver in
a non-COVID area that he either in the adult or pediatric sector.
Status | Not yet recruiting |
Enrollment | 130 |
Est. completion date | December 25, 2020 |
Est. primary completion date | June 25, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - caregivers staff assigned to a non-intensive care COVID service - or caregivers staff assigned to a non-COVID adult service - or caregivers staff assigned to a non-COVID pediatric service - Age > = 18 years old - With health insurance - Express consent Exclusion Criteria: - Protected persons - Refusal to participate |
Country | Name | City | State |
---|---|---|---|
France | CHU de Limoges | Limoges |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Limoges |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Seroconversion | Participants seroconverion will be assessed by analysing IgG When the seroconverion is confirmed (whenever it occurs), the participant ends his partipation. | Day1 | |
Primary | Seroconversion | Participants seroconverion will be assessed by analysing IgG When the seroconverion is confirmed (whenever it occurs), the participant ends his partipation. | Day 15 | |
Primary | Seroconversion | Participants seroconverion will be assessed by analysing IgG When the seroconverion is confirmed (whenever it occurs), the participant ends his partipation. | Day 30 |